Stock screenerAll disclosures →
EDGAR →
RARE
Conviction 43HealthcareScan · Mon, Aug 10, 2026Bullish engulfing
RARE$26.80+3.43%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.46M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price26.80
Change+3.43%
Gap-0.46%
Rel volume3.56×
Avg volume2.17M
Avg $ vol58.32M
SMA 2027.25
SMA 5027.69
SMA 20026.78
Price vs 50-3.20%
Price vs 200+0.06%
MA stackmixed
50/200 cross—
Supertrenddown · 29.15
RSI (14)47
MACD hist-0.12
MACD cross—
Stoch %K / %D58 / 42
ADX (14)25
+DI / −DI24 / 18
RSI divergence—
MACD divergence—
ATR %+5.95%
ADR %5.61%
52w high36.54
52w low18.50
From 52w high-26.66%
Above 52w low+44.86%
New 52w highNo
SqueezeOff
Bollinger width31.09%
%B0.45
Donchian pos29.15%
Donchian high33.58
Donchian low24.01
AVWAP (52w high)25.14
vs AVWAP high+6.60%
AVWAP (52w low)26.40
vs AVWAP low+1.52%
OBV trendFlat
Chaikin MF (20)-0.09
Today vs 20d3.56×
Avg vol (14d)2.46M
Avg vol (20d)2.17M
Avg $ vol (20d)58.32M
Market cap2.64B
RS 3m (vs SPY)-6.54%
RS 6m (vs SPY)-5.20%
RS line new highNo
Trend template2/8
Technical rank44.5
1 week+7.11%
1 month-20.76%
3 months+2.60%
6 months+8.50%
1 year-3.70%
YTD+13.56%
P/E-4.60
P/B-9.08
P/S3.93
P/FCF-5.60
EPS-5.83
Div yield—
ROE197.59%
ROA-45.49%
Debt/Eq—
Current1.73
EV/EBITDA-5.03
Gross margin—
Net margin-85.44%
Rev growth20.18%
EPS growth-1.05%
Price target50.93
Target upside90.04%
Analyst ratingBuy
Institutional116.34%
Ent. value2.52B
Revenue214M
Net income-92M
Gross profit—
Free cash flow-472M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out98.49M
Employees1.37K
ListedFri, Jan 31, 2014
Free float91.5M
Float %94.9%
Short interest13.44M
Days to cover6.9d
Short volume46.4%
Squeeze score74 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.90 vs −$1.27
Last surprise+29.1% beat
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank44.5 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RARE · 3 recent
Insider activity
SEC Form 4 transactions in RARE · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Horn Howard Chief Financial Officer · Common Stock · 2026-06-01 | Sell | 4.65K | $111K | 2026-06-01 | 2026-06-01 |
SULIMAN SHEHNAAZ Director · Common Stock · 2026-05-18 | Sell | 5.74K | $144K | 2026-05-18 | 2026-05-18 |
WELCH DANIEL G Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Dunsire Deborah Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Sanders Corazon (Corsee) D. Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Fust Matthew K Director · Stock Option (Right to Buy) · 2026-05-14 | Grant | 14.06K | $0 | 2026-05-14 | 2026-05-18 |
Ray Amrit Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
Fust Matthew K Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
WELCH DANIEL G Director · Stock Option (Right to Buy) · 2026-05-14 | Grant | 14.06K | $0 | 2026-05-14 | 2026-05-18 |
NARACHI MICHAEL Director · Common Stock · 2026-05-14 | Grant | 7.75K | $0 | 2026-05-14 | 2026-05-18 |
SEC filings
EDGAR filings in RARE · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.